Post-marketing Surveillance of the Safety, Tolerability and Efficacy of Desloratadine Tablet Among Filipino Patients
Phase of Trial: Phase IV
Latest Information Update: 29 Jan 2016
At a glance
- Drugs Desloratadine (Primary)
- Indications Allergic rhinitis; Urticaria
- Focus Adverse reactions
- Sponsors Schering-Plough
- 22 Jul 2009 Actual patient number (3011) added as reported by ClinicalTrials.gov.
- 01 Oct 2008 Actual end date (1 Dec 2007) added as reported by ClinicalTrials.gov.
- 01 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.